한국어
English
日本語
中文(简体)
Octairo Capsule 40 mg (Repotrectinib)
40mg
Hard capsule · Prescription medication
HanKook BMS Pharmaceutical Co., Ltd.
Repotrectinib is an anticancer drug used to treat cancers with specific gene mutations.
MFDS ingredient code M285531
Repotrectinib is an anticancer drug that targets specific gene mutations within cancer cells. It is primarily used to inhibit cancer growth by blocking abnormal signaling in cancer cells, such as in non-small cell lung cancer. This ingredient has been developed as a molecular targeted therapy.
Repotrectinib blocks the abnormal activation of specific proteins within cancer cells, thereby interrupting the signals that promote cancer cell proliferation. This results in suppression of cancer cell growth and reduction in tumor size. It acts selectively in patients with targeted gene mutations.
Approved uses differ by product. Check each product's information for its actual use.
Repotrectinib is a multi-target inhibitor that simultaneously suppresses multiple gene mutations. Unlike conventional single-target anticancer agents, it has characteristics that reduce the occurrence of resistance and enhance efficacy. Therefore, it may be more effective in treating cancers with specific mutations.
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Even with the same ingredient, dosage and approved uses can differ by strength, dosage form and combined ingredients. Check each product's information before taking it.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
Product approval information is based on drug information provided by the Ministry of Food and Drug Safety.
Ingredient and class descriptions are not part of MFDS data and were written separately by Cashdoc.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.
